This difference allows compounding under Section 503A to potentially continue, provided the prescribing physician documents a specific clinical reason for the compounded version over the commercial product
He L, et al
Can I get Wegovy on the NHS if I have CKD
Global, regional, and national prevalence of adult overweight and obesity, 19902021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021
Lingampelly SS, Naviaux JC, Heuer LS, Monk JM, Li K, Wang L, et al
Administration of a loading dose of PREG is associated with an increase in serum ALLO levels (192)